Melanoma cell lines and bladder tumor tissue samples were selected based on the loss of HLA haplotype (homozygous HLA genotype) with apparently positive HLA-ABC/β2M expression detected by flow cytometry or immunohistochemistry with some selective locus or allelic loss [27]. This evidence concerns the gene B2M and melanoma.